XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Mar. 31, 2018
Current Assets:    
Cash $ 6,697,838 $ 4,381,643
Accounts receivable, net of allowance for doubtful accounts of $17,046 at September 30, 2018 and $23,046 at March 31, 2018 1,066,411 1,201,117
Due from related parties 18,308 14,204
Inventories, at lower cost or market, principally average cost method 3,378,406 2,405,007
Prepaid expenses 401,753 321,074
Total Current Assets 11,562,716 8,323,045
Equipment, net of accumulated depreciation of $249,493 at September 30, 2018 and $113,158 at March 31, 2018 2,262,906 1,241,326
Other Assets:    
Deposits 148,463 16,300
Licensing agreements, net of accumulated amortization of $83,333 at September 30, 2018 and $58,333 at March 31, 2018 166,667 191,667
Patents, net of accumulated amortization of $92,164 at September 30, 2018 and $49,627 at March 31, 2018 857,836 900,373
Acquisition Deposit 250,000  
TOTAL ASSETS 15,248,588 10,672,711
Current Liabilities:    
Accounts payable 557,844 479,465
Accrued liabilities 402,653 541,210
Insurance premium note payable 27,909 99,907
Total Current Liabilities 988,406 1,120,582
Shareholders' Equity:    
Common Stock, $0.001 par value, 200,000,000 shares authorized 32,600,684 and 28,394,503 shares issued and outstanding at September 30, 2018 and March 31, 2018, respectively 32,601 28,394
Additional paid-in capital 25,329,998 17,264,888
Accumulated (Deficit) (11,102,417) (7,741,153)
Total Shareholders' Equity 14,260,182 9,552,129
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 15,248,588 $ 10,672,711